Categories: News

PRISM Vision Group Congratulates Reginald J. Sanders, M.D., FASRS

Dr. Reginald Sanders named President of the American Society of Retina Specialists (ASRS)

NEW PROVIDENCE, NJ / ACCESSWIRE / January 25, 2024 / The Retina Group of Washington and PRISM Vision Group are thrilled to announce that Reginald J. Sanders, M.D., FASRS, was recently named President of the American Society of Retina Specialists (ASRS). The ASRS is the world’s largest organization for retina specialists, serving as a national advocate and primary source of clinical and scientific information and education for its members.

Reginald J. Sanders, M.D., FASRS

Dr. Sanders is the first African American and the first PRISM-affiliated physician to serve as President of the ASRS. Throughout his career, Dr. Sanders has made significant contributions to ophthalmology, evidenced by numerous academic publications, impactful presentations, and a collection of well-deserved honors and awards. His exceptional achievements include his election as a charter inductee into the Retina Hall of Fame, further solidifying his standing as a leader in the field.

PRISM Vision Group congratulates Dr. Sanders and thanks him for all he has done to improve the lives of so many patients over the years.

Contact Information

Jennifer Shinners
VP Communications
jshinners@prismvisiongroup.com
6176783031

SOURCE: PRISM Vision Group

View the original press release on newswire.com.

Staff

Recent Posts

Bemax Announces Financial Results for Fiscal Fourth Quarter Ended May 31, 2024

- Revenue increase of over 600%Dallas, Georgia--(Newsfile Corp. - July 2, 2024) - Bemax Inc.…

47 mins ago

1933 Industries Reports Profit in Q3 2024 Financials

VANCOUVER, BC / ACCESSWIRE / July 2, 2024 / 1933 Industries Inc. (the "Company" or…

47 mins ago

Myriad Genetics Earns 2024 Great Place To Work® Certification™

SALT LAKE CITY, July 02, 2024 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a…

47 mins ago

Scilex Holding Company to Ring Nasdaq Closing Bell on Friday, July 5th at 4:00PM ET at the Nasdaq MarketSite in Times Square, New York

The ceremony will be held in celebration of Scilex’s launch of GLOPERBA®, an innovative non-opioid…

47 mins ago

Positive Phase 1 Clinical Data of MTX110 in DMG Brain Cancer Demonstrating Increased Survival Presented at ISPNO 2024

July 2, 2024 Biodexa Pharmaceuticals PLC Positive Phase 1 Clinical Data of MTX110 in DMG…

47 mins ago